Suppr超能文献

盐酸甲氧氯普胺骨架片的制备及体外释放度比较。

Preparation and comparative evaluation of sustained release metoclopramide hydrochloride matrix tablets.

机构信息

Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.

出版信息

Saudi Pharm J. 2009 Oct;17(4):283-8. doi: 10.1016/j.jsps.2009.10.004. Epub 2009 Nov 10.

Abstract

Metoclopramide hydrochloride (MCP) is commonly used for the management of gastrointestinal disorders. Frequent administration and the undesired side effects (extra pyramidal symptoms) of the drug on the central nervous system due to the fluctuations of its plasma concentrations may lead to patient incompliance, and hence, improper therapy. Therefore, the present work will be devoted to formulate the drug in sustained release formulations. MCP was incorporated in 12 formulae containing different polymers and/or different polymer ratios. These polymers were hydroxypropylmethyl cellulose (HPMC), carboxymethylcellulose (CMC) and ethyl cellulose (EC). Sodium starch glycolate (SSG) was added to some formulae in different amounts in order to soften and/or disintegrate the tablets. Both direct compression and granulation techniques were used to prepare the tablets. The physical properties were found to be satisfactory for all the formulae. The dissolution profiles of the tablets were constructed using the change-over method. The drug release involved a combination of both diffusion and polymer-chain relaxation mechanisms. The time required to release 50% of MCP ranged from 1.2 to more than 8 h. Direct compression and dry granulation techniques produced sufficient sustaining of the drug release. However, the pellets made by wet granulation released MCP in about 2 h, i.e., pelletization spheronization technique was not effective in sustaining the drug.

摘要

盐酸甲氧氯普胺(MCP)常用于治疗胃肠道疾病。由于其血浆浓度波动,药物频繁给药和对中枢神经系统的不良副作用(锥体外系症状)可能导致患者不遵医嘱,从而导致治疗不当。因此,本工作将致力于将药物制成缓控释制剂。MCP 被包含在 12 种含有不同聚合物和/或不同聚合物比例的配方中。这些聚合物为羟丙基甲基纤维素(HPMC)、羧甲基纤维素(CMC)和乙基纤维素(EC)。为了软化和/或崩解片剂,一些配方中添加了不同量的交联羧甲基纤维素钠(SSG)。使用直接压片和制粒技术来制备片剂。所有配方的物理性质都令人满意。使用转换法构建了片剂的溶解曲线。药物释放涉及扩散和聚合物链松弛机制的组合。释放 50%MCP 所需的时间范围为 1.2 小时至 8 小时以上。直接压片和干法制粒技术能够充分维持药物释放。然而,通过湿法制粒制成的丸粒在大约 2 小时内释放 MCP,即制粒-滚圆技术在维持药物释放方面效果不佳。

相似文献

5

本文引用的文献

6
Chitosan and chondroitin microspheres for oral-administration controlled release of metoclopramide.
Eur J Pharm Biopharm. 1999 Sep;48(2):149-55. doi: 10.1016/s0939-6411(99)00040-5.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验